Prothrombin complex deficiency procedure manual

Use of Human Prothrombin Complex Concentrate in Patients with Acquired Deficiency and Active or in High-Risk Severe Bleeding Mendarte L1, Munne M1, Rodri guez S2, Mendarte U3 and Montoro JB1 Affiliations: 1Pharmacy Service; 2Haematology Service and 3Digestive Service, Donostia Ospitalea, Donostia, Hospital Universitario Vall d'Hebron, Barcelona, Spain Hypoprothrombinemia is a rare blood disorder in which a deficiency in immunoreactive prothrombin (Factor II), produced in the liver, results in an impaired blood clotting reaction, leading to an increased physiological risk for spontaneous bleeding. This condition can be observed in the gastrointestinal system, cranial vault, and superficial integumentary system, effecting both the male and 3. Bleeding or procedure in patients with congenital deficiencies of factors II, V, VII, X, XI or XIII. 4. Correction of warfarin overdose. Note: in life-threatening bleeding Kcentra (4 factor Prothrombin Complex Concentrate) should be used. 5. Treatment of specific plasma factor deficiencies: Note: Prothrombin complex concentrate (Human) [(Factors II, VII, IX, X), Protein C, Protein S] contains therapeutic levels of factor VII component and should not be confused with Factor IX complex (Human) [Factors II, IX, X] (Bebulin, Profilnine) which contains low or nontherapeutic levels of factor VII. Apply firm pressure with sterile gauze after remove needle -check arm and apply bandaid. Donor should remain in donor chair under observation. Observe donors while sit up and escort to refreshment area (eat and drink something before leaving, drink more fluids furing next 4 hrs, avoid alcohol until eat next meal, no smoking 30 min, resume normal activities if asymptomatic). Factor II (also called prothrombin) deficiency is an inherited bleeding disorder that is caused by a problem with factor II. Because the body produces less prothrombin than it should, or because the prothrombin is not working properly, the clotting reaction is